Research map: Prognostic factor analysis of CD19 CAR-T therapy followed by hematopoietic stem cell transplantation in relapsed/refractory B-ALL

Back to the article

Papers in this map

  1. ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells · Daniel W. Lee · 2018 · 3668 citations · Cited by this paper
  2. LRP8 drives cervical cancer lymph node metastasis by promoting epithelial-mesenchymal transition and VEGF-C secretion · 2026 · Related
  3. Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia · Jae H. Park · 2018 · 2735 citations · Cited by this paper
  4. Global trends in the burden of inflammatory bowel disease from 1990 to 2021: socioeconomic and sex-specific disparities with exploratory mendelian randomization analyses · 2026 · Related
  5. Acute Lymphoblastic Leukemia in Children · Stephen P. Hunger · 2015 · 2276 citations · Cited by this paper
  6. Extranodal involvement defines distinct immune-molecular phenotypes and clinical outcomes in diffuse large b-cell lymphoma · 2026 · Related
  7. Defining the Intensity of Conditioning Regimens: Working Definitions · Andrea Paolo Bacigalupo · 2009 · 1844 citations · Cited by this paper
  8. Pan-cancer analysis identifies KANSL2 as a cell-cycle–associated regulator of tumor progression and immunity in liver hepatocellular carcinoma · 2026 · Related
  9. Acute lymphoblastic leukemia: a comprehensive review and 2017 update · Toby Terwilliger · 2017 · 1323 citations · Cited by this paper
  10. Serum TIMP-1 shows a potential association with metastatic disease in patients with pancreatic cancer: a pilot analysis without a healthy control cohort · 2026 · Related
  11. Treating Childhood Acute Lymphoblastic Leukemia without Cranial Irradiation · Ching‐Hon Pui · 2009 · 1236 citations · Cited by this paper
  12. Integrated bioinformatic evaluation unveils a cellular senescence gene signature as a poor prognostic factor in hepatocellular carcinoma · 2026 · Related
  13. Cytokine release syndrome and associated neurotoxicity in cancer immunotherapy · Emma C. Morris · 2021 · 1120 citations · Cited by this paper
  14. Population-specific association and risk discrimination utility of the cardiometabolic index for prevalent hypertension–diabetes comorbidity: insights from CHARLS and NHANES · 2026 · Related
  15. International, Multicenter Standardization of Acute Graft-versus-Host Disease Clinical Data Collection: A Report from the Mount Sinai Acute GVHD International Consortium · Andrew C. Harris · 2015 · 1034 citations · Cited by this paper
  16. Beyond polarization: a receptor-centered framework for macrophage function and therapy in skin diseases · 2026 · Related
  17. Acute lymphoblastic leukaemia · Florent Malard · 2020 · 782 citations · Cited by this paper
  18. Dissecting PCD-driven molecular landscapes in AML: a multi-omic framework for prognostication and therapeutic targeting · 2026 · Related
  19. Induction therapy for adults with acute lymphoblastic leukemia: results of more than 1500 patients from the international ALL trial: MRC UKALL XII/ECOG E2993 · Jacob M. Rowe · 2005 · 689 citations · Cited by this paper
  20. Cell death pathways in graft-versus-host disease · 2026 · Related
  21. Association of Minimal Residual Disease With Clinical Outcome in Pediatric and Adult Acute Lymphoblastic Leukemia · Donald A. Berry · 2017 · 597 citations · Cited by this paper
  22. Modern Therapy of Acute Lymphoblastic Leukemia · Renato Bassan · 2011 · 489 citations · Cited by this paper
  23. From bench to bedside: the history and progress of CAR T cell therapy · Aroshi Mitra · 2023 · 465 citations · Cited by this paper
  24. Factors associated with durable EFS in adult B-cell ALL patients achieving MRD-negative CR after CD19 CAR T-cell therapy · Kevin Anthony Hay · 2019 · 410 citations · Cited by this paper
  25. Hematopoietic stem cell transplantation for patients with AML in first complete remission · Jan J. Cornelissen · 2015 · 351 citations · Cited by this paper
  26. Catch me if you can: Leukemia Escape after CD19-Directed T Cell Immunotherapies · Marco Ruella · 2016 · 293 citations · Cited by this paper
  27. Efficacy and safety of anti-CD19 CAR T-cell therapy in 110 patients with B-cell acute lymphoblastic leukemia with high-risk features · Xian Zhang · 2020 · 223 citations · Cited by this paper
  28. Allogeneic hematopoietic cell transplantation: the state of the art · Boglarka Gyurkocza · 2010 · 204 citations · Cited by this paper
  29. Late effects of blood and marrow transplantation · Yoshihiro Inamoto · 2017 · 169 citations · Cited by this paper
  30. Anti‐CD19 chimeric antigen receptor‐modified T‐cell therapy bridging to allogeneic hematopoietic stem cell transplantation for relapsed/refractory B‐cell acute lymphoblastic leukemia: An open‐label pragmatic clinical trial · Huiwen Jiang · 2019 · 145 citations · Cited by this paper
  31. Graft-versus-host disease versus graft-versus-leukemia · Robert S. Negrin · 2015 · 107 citations · Cited by this paper
  32. Non-HLA immunogenetic polymorphisms and the risk of complications after allogeneic hemopoietic stem-cell transplantation · Charles Grenfell Mullighan · 2004 · 88 citations · Cited by this paper
  33. Pre-transplant MRD negativity predicts favorable outcomes of CAR-T therapy followed by haploidentical HSCT for relapsed/refractory acute lymphoblastic leukemia: a multi-center retrospective study · Houli Zhao · 2020 · 86 citations · Cited by this paper
  34. Allogeneic hematopoietic cell transplantation, the microbiome, and graft-versus-host disease · Yannouck F. van Lier · 2023 · 58 citations · Cited by this paper
  35. Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia; Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia; Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia · 2016 · 45 citations · Cited by this paper
  36. Anti-CD19 CAR-T cell therapy bridge to HSCT decreases the relapse rate and improves the long-term survival of R/R B-ALL patients: a systematic review and meta-analysis · Linhui Hu · 2021 · 37 citations · Cited by this paper
  37. Comparison of blinatumomab and CAR T-cell therapy in relapsed/refractory acute lymphoblastic leukemia: a systematic review and meta-analysis · Yixin Zhai · 2023 · 24 citations · Cited by this paper
  38. CD19 CAR-T cell treatment conferred sustained remission in B-ALL patients with minimal residual disease · Wenyi Lu · 2021 · 23 citations · Cited by this paper
  39. Shortening the ex vivo culture of CD19‐specific CAR T‐cells retains potent efficacy against acute lymphoblastic leukemia without CAR T‐cell‐related encephalopathy syndrome or severe cytokine release syndrome · Sanfang Tu · 2019 · 22 citations · Cited by this paper

Source: OpenAlex (CC0)